Patent details

Basic Information

Publication number:

EP2563391

PCT Application Number:

EP2011056461

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117164020

PCT Publication Number:

WO2011134899

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR

French Title of Invention:

Polythérapie d'un anticorps CD20 afucosylaté avec un inhibiteur mTOR

German Title of Invention:

Kombinationstherapie eines afucosylierten CD20-Antikörpers mit einem mTOR-Inhibitor

SPC Number:

Dates

Filing date:

21/04/2011

Grant date:

26/08/2020

EP Publication Date:

06/03/2013

PCT Publication Date:

03/11/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/08/2020

EP B1 Publication Date:

26/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/04/2021

Expiration date:

21/04/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/08/2020

 

 

Name:

Roche Glycart AG

Address:

Wagistrasse 18, 8952 Schlieren, Switzerland (CH)

Inventor

1

Name:

KLEIN, Christian

Address:

Switzerland (CH)

2

Name:

HERTING, Frank

Address:

Germany (DE)

Priority

Priority Number:

10161181

Priority Date:

27/04/2010

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/00; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202035

Publication date:

26/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages